Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Numinus Wellness's Days Sales Outstanding or its related term are showing as below:
NUMIF's Days Sales Outstanding is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 45.835 * Ranked among companies with meaningful Days Sales Outstanding only.
Numinus Wellness's Days Sales Outstanding
declined
from May. 2024 (171.33) to May. 2025 (65.38).
Numinus Wellness (OTCPK:NUMIF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Numinus Wellness Days Sales Outstanding Related Terms
Numinus Wellness Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Numinus Wellness's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NUMIF vs HLYK, SYRA, GBCS: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, Numinus Wellness's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Numinus Wellness Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Numinus Wellness's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Numinus Wellness's Days Sales Outstanding falls into.
Numinus Wellness Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Numinus Wellness (NUMIF) has a Days Sales Outstanding of 65.38 as of May. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Numinus Wellness and its competitors.
Is Numinus Wellness' Days Sales Outstanding too high?
Numinus Wellness' current Days Sales Outstanding is 65.38. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.84. Numinus Wellness' value of 65.38 is 42.6% above this industry median.
How does Numinus Wellness' Days Sales Outstanding compare to HLYK and SYRA?
Numinus Wellness' Days Sales Outstanding of 65.38 can be compared against companies in the Healthcare Providers & Services industry. The industry median Days Sales Outstanding is 45.84. Numinus Wellness' value of 65.38 is 42.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.84, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Numinus Wellness's current Days Sales Outstanding of 65.38 is 42.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Numinus Wellness and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Numinus Wellness's current Days Sales Outstanding is 65.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numinus Wellness stock overvalued right now?
Numinus Wellness (NUMIF) has a current Days Sales Outstanding of 65.38. The current Days Sales Outstanding is 65.38 and 42.6% above the Healthcare Providers & Services industry median of 45.84. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Numinus Wellness (NUMIF), the current Days Sales Outstanding is 65.38 as of May. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NUMIF has been successfully added to your 
